Provectus Pharmaceuticals, Inc.
7327 Oak Ridge Highway, Suite A
Knoxville, Tennessee 37931
(865) 769-4011
July 19, 2004
U.S. Securities and Exchange Commission
450 Fifth Street, N.W., Judiciary Plaza
Washington, D.C. 20549
Attn: Mr. Jeffrey P. Riedler, Assistant Director
VIA EDGAR
Re: Provectus Pharmaceuticals, Inc.
Registration Statement of Form S-2
Registration No. 333-112762
Ladies and Gentlemen:
Provectus Pharmaceuticals, Inc., a Nevada corporation (the "Registrant"),
hereby requests, pursuant to Rule 477(a) of the Securities Act of 1933, as
amended (the "Act"), that the Securities and Exchange Commission (the
"Commission") consent to the withdrawal of the Registrant's Registration
Statement on Form S-2 (Registration No. 333-112762), which previously was filed
with the Commission on February 12, 2004 and subsequently amended on April 7,
2004 (the "Registration Statement").
The Registrant is requesting the withdrawal of the Registration Statement
because the holders of the securities for which the Registration Statement was
principally filed no longer are requiring the Registrant to pursue the
registration of the securities.
The Registration Statement has not been declared effective by the
Commission and no securities have been sold under the Registration Statement.
The Registrant requests, in accordance with Rule 457(p) of the Act, that all
fees paid to the Commission in connection with the filing of the Registration
Statement be credited to the Registrant's account for future use.
Please direct any questions regarding this filing to the undersigned at
865-769-4011, H. Craig Dees (865-769-4011) or Linda M. Crouch-McCreadie
(423-928-0181), counsel to the Registrant.
Very truly yours,
/s/ Timothy C. Scott
------------------------------------------------
Timothy C. Scott
President
Provectus Pharmaceuticals, Inc.